A study to compare the duration of pain free period after surgery when Butorphanol and Tramadol given with Levobupivacaine in brachial plexus block
Not Applicable
- Conditions
- Health Condition 1: S529- Unspecified fracture of forearm
- Registration Number
- CTRI/2022/04/041666
- Lead Sponsor
- Dr Jaya Lalwani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. ASA grade I to III
2. Patients undergoing elective below elbow upper limb surgery under ultra sound guided supraclavicular brachial plexus block
Exclusion Criteria
1. Patient refusal
2. Local infection at injection site
3. Failure of block
4. Any bleeding disorder and patient on anticoagulants
5. Allergy to study drugs
6. Severe respiratory, renal and liver disorder
7. Glucose intolerance and diabetic patient
8. Neurological deficit involving brachial plexus
9. Morbidly obese
10. Pregnant women
11. Drug abuse
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of postoperative analgesia <br/ ><br> <br/ ><br>Timepoint: First 24 hours of postoperative period <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method â®? Assessment of pain using VAS <br/ ><br> <br/ ><br> <br/ ><br>â®? Onset of sensory and motor blockade <br/ ><br> <br/ ><br> <br/ ><br>â®? Duration of sensory and motor blockade <br/ ><br> <br/ ><br> <br/ ><br>â®? Adverse effectsâ?? CNS toxicity [convulsion, coma], CVS toxicity [tachycardia, arrhythmias], respiratory depression, nausea, vomiting, allergic reactions, pneumothorax, Horners syndrome and recurrent laryngeal nerve block. <br/ ><br>Timepoint: First 24 hours of postoperative period <br/ ><br> <br/ ><br>